Qualcomms AI Device Boom Drives Investor Enthusiasm Morgan Stanley Highlights Potential Turnaround for Franklin Resources BEN Wolfe Research Names Amazon AMZN a Top Pick in the Internet Sector Chinas DeepSeek Challenges AI Cost Paradigm with LowChip Strategy IFB Industries Q4 Net Profit Surges to Rs 4267 Crore Revenue Climbs 1233 RBIs Surprise Rate Cut Raises Questions on Policy Framework Nomura Says MPLX Q1 2026 Earnings EPS Misses Estimates by 156 Amid Stable Distribution Outlook Amplitech Group Inc AMPGZ Q1 2026 Earnings EPS Miss and Steep Stock Decline Highlight Ongoing Challenges Builders FirstSource BLDR Q1 2026 Earnings EPS Misses Estimates Amid Market Challenges Pineapple Financial Inc PAPL Q3 2025 Earnings Narrowing Losses Beat Expectations Yet Shares Slip iHeartMedia IHRT Q1 2026 Earnings EPS Misses Estimates Stock Rallies Despite Loss Via Transportation Inc VIA Q1 2026 Earnings EPS Beat Exceeds Estimates by 1319 TKO Group Holdings Inc TKO Holds Steady Near 190 as Traders Weigh Support and Resistance Stereotaxis STXS Edges Higher Navigating the Robotics Sector with Modest Gains Amylyx Pharmaceuticals AMLX Declines 25 as Stock Tests Key Support SAIC SAIC Rallies 2 as Stock Holds Key Support Level Weatherford International WFRD Holds Steady Near Support Amid Quiet Trading SP 500 Inches Higher as Healthcare and Tech Lead Broad Gains MWA Q1 2026 Earnings Earnings Per Share Beat Expectations Despite Modest Stock Decline AutoZone AZO Slips 23 as Key Support Level Comes Into View MHO Q1 2026 Earnings EPS Slightly Beats Estimate Stock Holds Steady Revelation Biosciences Q1 2026 Earnings EPS Miss Highlights Ongoing PreRevenue Stage CKX Lands Inc Q1 2025 Earnings Positive EPS Signals Operational Stability Amidst Revenue Uncertainty GT Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares OXLCP Q4 2025 Earnings EPS Misses Estimates by 74 as Shares Edge Higher Affinity Bancshares Q3 2023 Earnings Solid EPS Performance Amidst Modest Stock Reaction ACTU Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline